CTIC   $9.09  0.0 Market Closed

CTI BioPharma Corp
Last Events:

2023-07-18 Trend pattern changed from расширяющаяся формация to расходящийся клин с наклоном вверх.

2023-07-18 Signal in Stochastic changed from bullish recovery to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: main and signal line crossing.

2023-07-18 Signal in MACD changed from bullish recovery to bearish reversal. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: exit from the overbought zone.

2023-07-18 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

2023-07-18 Trend Power changed from to medium strength.

2023-07-18 Trend changed from down and flat to turning up.

2023-05-20 Signal in Stochastic changed from bearish reversal to bullish recovery. The stochastic indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: main and signal line crossing.

2023-05-20 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.


Current temperature: 0.00
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 6.55
Target: 10.49
High with 50% probability: 12.00
Analyst Recommendations:
Number of estimates 7
Target Price Mean 10.49
Mean unverified/preliminary 10.49 / 10.49
Target Price Low / High 9.00 / 15.00
Median / STD DEV 9.10 / 2.47
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total - - -
rsi ActivelyBuy - -
macd - - -
stoch - - -
ma20 ActivelyBuy Buy -
ma50 - - -
ma100 - - -
Candlestick PatternJune 15, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US12648L6011
ceo Dr. Adam R. Craig M.B.A., M.D., Ph.D.
Website https://www.ctibiopharma.com
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an an oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTI BioPharma Corp. has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. and S*BIO Pte Ltd. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.